Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam

Varun Sreenivasan, Arkadiusz Z. Dudek

Research output: Contribution to journalArticlepeer-review

Abstract

Dystonia has been described as a potential toxicity of radiation therapy. Management of this rare movement disorder is targeted in symptom improvement. We report a case of a 46-year-old female patient who developed dystonia during treatment of melanoma metastatic to the brain and discuss potential causes of and therapies for this rare complication.

Original languageEnglish (US)
Pages (from-to)78-83
Number of pages6
JournalCase Reports in Oncology
Volume6
Issue number1
DOIs
StatePublished - Jan 1 2013

Keywords

  • Brain metastasis
  • Dystonia
  • Gamma Knife therapy
  • High-dose interleukin-2
  • Levetiracetam
  • Melanoma

Fingerprint Dive into the research topics of 'Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam'. Together they form a unique fingerprint.

Cite this